Temporal dynamics in viral shedding and transmissibility of COVID-19
- PMID: 32296168
- DOI: 10.1038/s41591-020-0869-5
Temporal dynamics in viral shedding and transmissibility of COVID-19
Erratum in
-
Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19.Nat Med. 2020 Sep;26(9):1491-1493. doi: 10.1038/s41591-020-1016-z. Nat Med. 2020. PMID: 32770170 Free PMC article.
Abstract
We report temporal patterns of viral shedding in 94 patients with laboratory-confirmed COVID-19 and modeled COVID-19 infectiousness profiles from a separate sample of 77 infector-infectee transmission pairs. We observed the highest viral load in throat swabs at the time of symptom onset, and inferred that infectiousness peaked on or before symptom onset. We estimated that 44% (95% confidence interval, 25-69%) of secondary cases were infected during the index cases' presymptomatic stage, in settings with substantial household clustering, active case finding and quarantine outside the home. Disease control measures should be adjusted to account for probable substantial presymptomatic transmission.
Comment in
-
COVID-19 infectivity profile correction.Swiss Med Wkly. 2020 Aug 5;150:w20336. doi: 10.4414/smw.2020.20336. eCollection 2020 Jul 27. Swiss Med Wkly. 2020. PMID: 32757177 No abstract available.
-
Reply to: Is presymptomatic spread a major contributor to COVID-19 transmission?Nat Med. 2020 Oct;26(10):1534-1535. doi: 10.1038/s41591-020-1049-3. Epub 2020 Aug 17. Nat Med. 2020. PMID: 32807935 No abstract available.
-
Is presymptomatic spread a major contributor to COVID-19 transmission?Nat Med. 2020 Oct;26(10):1531-1533. doi: 10.1038/s41591-020-1046-6. Epub 2020 Aug 17. Nat Med. 2020. PMID: 32807936 No abstract available.
Similar articles
-
SARS-CoV-2: The viral shedding vs infectivity dilemma.Infect Dis Health. 2020 Aug;25(3):210-215. doi: 10.1016/j.idh.2020.05.002. Epub 2020 May 20. Infect Dis Health. 2020. PMID: 32473952 Free PMC article.
-
The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients.J Med Virol. 2020 Jul;92(7):833-840. doi: 10.1002/jmv.25825. Epub 2020 Apr 25. J Med Virol. 2020. PMID: 32243607
-
Serial interval of novel coronavirus (COVID-19) infections.Int J Infect Dis. 2020 Apr;93:284-286. doi: 10.1016/j.ijid.2020.02.060. Epub 2020 Mar 4. Int J Infect Dis. 2020. PMID: 32145466 Free PMC article.
-
Ocular Symptoms of SARS-CoV-2: Indication of Possible Ocular Transmission or Viral Shedding.Ocul Immunol Inflamm. 2020 Nov 16;28(8):1269-1279. doi: 10.1080/09273948.2020.1799035. Epub 2020 Sep 1. Ocul Immunol Inflamm. 2020. PMID: 32870054 Review.
-
Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases.BMJ Open. 2020 Aug 5;10(8):e039856. doi: 10.1136/bmjopen-2020-039856. BMJ Open. 2020. PMID: 32759252 Free PMC article. Review.
Cited by
-
Acoustic and Clinical Data Analysis of Vocal Recordings: Pandemic Insights and Lessons.Diagnostics (Basel). 2024 Oct 12;14(20):2273. doi: 10.3390/diagnostics14202273. Diagnostics (Basel). 2024. PMID: 39451596 Free PMC article.
-
Potential application of menadione for antimicrobial coating of surgical sutures.Biotechnol Notes. 2023 Feb 9;4:20-27. doi: 10.1016/j.biotno.2023.02.001. eCollection 2023. Biotechnol Notes. 2023. PMID: 39416925 Free PMC article.
-
Personal characteristics and transmission dynamics associated with SARS-CoV-2 semi-quantitative PCR test results: an observational study from Belgium, 2021-2022.Front Public Health. 2024 Sep 10;12:1429021. doi: 10.3389/fpubh.2024.1429021. eCollection 2024. Front Public Health. 2024. PMID: 39319296 Free PMC article.
-
Effectiveness of inactivated COVID-19 vaccines in preventing COVID-19-related hospitalization during the Omicron BF.7-predominant epidemic wave in Beijing, China: a cohort study.BMC Infect Dis. 2024 Sep 17;24(1):991. doi: 10.1186/s12879-024-09889-7. BMC Infect Dis. 2024. PMID: 39289630 Free PMC article.
-
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications.Mol Ther Nucleic Acids. 2024 Aug 19;35(3):102313. doi: 10.1016/j.omtn.2024.102313. eCollection 2024 Sep 10. Mol Ther Nucleic Acids. 2024. PMID: 39281702 Free PMC article. Review.
References
-
- Li, Q. et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med. 382, 1199–1207 (2020). - DOI
-
- Wu, J. T., Leung, K. & Leung, G. M. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet 395, 689–697 (2020). - DOI
-
- Peiris, J. S. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767–1772 (2003). - DOI
-
- Pitzer, V. E., Leung, G. M. & Lipsitch, M. Estimating variability in the transmission of severe acute respiratory syndrome to household contacts in Hong Kong, China. Am. J. Epidemiol. 166, 355–363 (2007). - DOI
-
- Riley, S. et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 300, 1961–1966 (2003). - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources